Clinical use of Anti-Müllerian Hormone to monitor resumption of ovarian activity following removal of a 4.7 mg deslorelin implant in queens

Ferré-Dolcet, L. ; Ferro, S. ; Contiero, B. ; Fontaine, C. ; Badon, T. ; Gelli, D. ; Romagnoli, S.

Veterinary research communications, 2022-09, Vol.46 (3), p.917-924 [Periódico revisado por pares]

Dordrecht: Springer Netherlands

Texto completo disponível